Psychiatry & Neurology Doctors in Port Orange, FL Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Dr. Timothy J Wierzbicki, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1211 Dunlawton Ave, Port Orange, FL 32127 Phone: 386-304-0111

Dr. Robert Daniel Colucci, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 740 Dunlawton Ave, Port Orange, FL 32127 Phone: 386-763-1000

Dr. Greg Alan Schaublin, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 5354 Coquina Shores Ln, Port Orange, FL 32128 Phone: 615-346-8182    Fax: 615-829-8970

Anthony Capozzi, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1730 Dunlawton Ave Ste 3, Port Orange, FL 32127 Phone: 386-957-3905

Dr. Jeremy R Grimes, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 Dunlawton Ave, Suite 103, Port Orange, FL 32127 Phone: 386-679-3270    Fax: 386-256-2518

Dr. Gary William Frick, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 790 Dunlawton Avenue, Suite J, Port Orange, FL 32127 Phone: 386-767-8584    Fax: 386-767-8536

News Archive

Enzyme therapy with agalsidase alfa may slow the progression of kidney disease

For men with Fabry disease, enzyme replacement therapy (ERT) with agalsidase alfa slows deterioration of kidney function, reports a study in the online edition of the Journal of the American Society of Nephrology (JASN).

Ingenuity iReport for Real-Time PCR optimized for TaqMan Gene Expression Assays

Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, and Life Technologies Corporation today announced Ingenuity iReport for Real-Time PCR optimized for TaqMan Gene Expression Assays.

Foot and ankle assessments fail to capture patient concerns

Commonly used clinical measurements of foot and ankle outcome do not reflect patient concerns, missing the impact of age and gender on how patients define treatment success, US researchers caution.

MicroPulse protocol as effective as ETDRS in treatment of DME: Study

IRIDEX Corporation announced the recent publication of a clinical study comparing results obtained in the treatment of diabetic macular edema (DME) using an IRIDEX laser and MicroPulse™ treatment protocol to those obtained using the recognized standard of care Early Treatment of Diabetic Retinopathy Study (ETDRS) laser protocol.

Read more Medical News

› Verified 5 days ago